GO:0160151 tRNA pseudouridine(32) synthase activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0160151 describes the molecular function of catalyzing the conversion of uridine(32) in tRNA to pseudouridine(32).
This activity is essential for proper tRNA structure and function, influencing translation fidelity and efficiency.
The Escherichia coli RluA protein is a well-characterized enzyme with this activity, and its deletion or mutation affects ribosomal RNA and tRNA pseudouridylation.
Dysregulation of tRNA modifications, including pseudouridylation, has been linked to various human diseases, though direct evidence for GO:0160151 in disease is still emerging.
Studying this activity requires methods such as RNA sequencing, mass spectrometry, and CRISPR-based gene editing to manipulate candidate genes.
EDITGENE provides specialized CRISPR services to create knockout, point-mutation, knock-in, and overexpression models for investigating tRNA pseudouridine(32) synthase activity.

Description

GO:0160151, tRNA pseudouridine(32) synthase activity, is a molecular function that catalyzes the isomerization of uridine at position 32 of tRNA to pseudouridine. This modification is one of the most abundant in RNA and plays a critical role in stabilizing tRNA structure and optimizing codon-anticodon interactions during translation. Researchers study this activity to understand how post-transcriptional modifications regulate protein synthesis and how their dysregulation contributes to disease. The enzyme RluA in Escherichia coli is a prototype for this activity, and its functional characterization has provided insights into the broader family of pseudouridine synthases. Understanding GO:0160151 is therefore fundamental for both basic RNA biology and translational research.

tRNA pseudouridine(32) synthase activity At A Glance

GO ID GO:0160151
GO term tRNA pseudouridine(32) synthase activity
Ontology molecular_function
Synonym None
Definition Catalysis of the reaction: uridine(32) in tRNA = pseudouridine(32) in tRNA.
Major function Post-transcriptional modification of tRNA
Representative enzyme RluA (E. coli)
Cellular location Cytoplasm (tRNA modification)
Associated process tRNA processing and translation

What Is GO:0160151?

According to the Gene Ontology, GO:0160151 is defined as the catalysis of the reaction: uridine(32) in tRNA = pseudouridine(32) in tRNA. In other words, it is the enzymatic activity that converts a specific uridine residue at position 32 of a tRNA molecule into pseudouridine, a modified nucleoside. This activity is a molecular function and is distinct from other pseudouridine synthases that act on different positions or RNA types.

Why Is tRNA pseudouridine(32) synthase activity Important in Cell Biology?

tRNA pseudouridine(32) synthase activity is crucial for maintaining the structural integrity and function of tRNA, which directly impacts translation efficiency and fidelity. Pseudouridine at position 32 helps stabilize the anticodon loop, facilitating proper codon recognition and preventing frameshifting. Disruptions in this modification can lead to aberrant protein synthesis, which is implicated in various diseases, including cancer and neurological disorders. Therefore, understanding this activity provides a window into the role of RNA modifications in health and disease, and it offers potential targets for therapeutic intervention.
Essential for tRNA stability and function.
Influences translation fidelity and efficiency.
Linked to cellular stress responses and disease.
Provides a model for studying RNA modification enzymes.
Potential biomarker for cancer and other diseases.
Target for drug discovery aiming to modulate translation.
Helps understand antibiotic resistance mechanisms in bacteria.
Relevant for synthetic biology and codon optimization.

Molecular Mechanism of tRNA pseudouridine(32) synthase activity

Substrate Recognition and Binding
In simple terms: The enzyme finds and grabs the tRNA molecule at a specific spot.
The enzyme specifically recognizes tRNA molecules and binds to them, positioning the uridine at position 32 for modification. This recognition involves interactions with the overall tRNA structure and specific nucleotides, ensuring that only the correct uridine is targeted.
Catalytic Mechanism of Pseudouridylation
In simple terms: The enzyme chemically changes uridine into pseudouridine.
The catalytic mechanism involves the cleavage of the glycosidic bond between the uracil base and the ribose sugar, followed by rotation of the base and reattachment to form pseudouridine. This isomerization is a multi-step process that requires precise coordination of catalytic residues within the enzyme active site.
Cofactors and Energy Requirements
In simple terms: The reaction does not need extra energy molecules; it is a simple rearrangement.
Pseudouridine synthases, including the enzyme responsible for GO:0160151, do not require ATP or other cofactors for catalysis; the reaction is an isomerization that proceeds without external energy input. This distinguishes them from many other RNA-modifying enzymes.
Regulation of Enzyme Activity
In simple terms: The enzyme's activity can be controlled by the cell.
The activity of tRNA pseudouridine(32) synthase can be regulated at the level of gene expression, enzyme stability, or post-translational modifications, although specific regulatory mechanisms for this enzyme are still being elucidated. In bacteria, the expression of RluA may be coordinated with ribosomal RNA and tRNA synthesis to meet cellular demands.

Key Genes Involved in GO:0160151 tRNA pseudouridine(32) synthase activity

The following genes and proteins are key players in tRNA pseudouridine(32) synthase activity and related tRNA modification pathways.
GeneMajor RoleResearch Relevance
RluA (E. coli)Catalyzes pseudouridine formation at position 32 in tRNA and position 746 in 23S rRNAModel enzyme for studying pseudouridine synthase activity and substrate specificity
PUS1 (human)Pseudouridine synthase that modifies tRNA and other RNAsImplicated in mitochondrial myopathy and sideroblastic anemia; potential link to tRNA modification defects
PUS3 (human)Pseudouridine synthase specific for position 38/39 in tRNAMutations cause intellectual disability; highlights importance of tRNA modifications in neurodevelopment
PUS7 (human)Pseudouridine synthase that modifies tRNA and other RNAsAssociated with intellectual disability and cancer; role in stem cell differentiation
DKC1 (human)Pseudouridine synthase in telomerase and H/ACA ribonucleoproteinMutations cause dyskeratosis congenita; links pseudouridylation to telomere maintenance
NOP10 (human)Accessory protein for H/ACA snoRNPsRequired for pseudouridylation of rRNA and tRNA; mutations cause dyskeratosis congenita
GAR1 (human)Accessory protein for H/ACA snoRNPsEssential for pseudouridine synthase activity in ribosome biogenesis
NHP2 (human)Accessory protein for H/ACA snoRNPsMutations linked to dyskeratosis congenita and cancer
TruB (E. coli)Pseudouridine synthase for position 55 in tRNAModel for studying tRNA pseudouridylation and its role in translation
TruA (E. coli)Pseudouridine synthase for position 38/39/40 in tRNAInvolved in tRNA stability and translation fidelity
RluB (E. coli)Pseudouridine synthase for 23S rRNARelated to RluA; helps understand substrate diversity
RluC (E. coli)Pseudouridine synthase for 23S rRNAModel for studying rRNA modification
RluD (E. coli)Pseudouridine synthase for 23S rRNAEssential for ribosome function; deletion affects growth
RsuA (E. coli)Pseudouridine synthase for 16S rRNAInvolved in ribosome assembly and function
PUS10 (human)Pseudouridine synthase involved in tRNA and miRNA processingLinked to cancer and immune regulation
PUS7L (human)Pseudouridine synthase-like proteinPotential role in tRNA modification; understudied
PUSL1 (human)Pseudouridine synthase-like proteinMay modify tRNA; function not fully characterized

How Is tRNA pseudouridine(32) synthase activity Regulated?

The regulation of tRNA pseudouridine(32) synthase activity is not fully understood, but it is likely controlled at multiple levels. In bacteria, the expression of RluA may be regulated in response to growth conditions and stress, ensuring adequate tRNA modification for protein synthesis. In eukaryotes, pseudouridine synthases can be regulated by post-translational modifications and interactions with accessory proteins, as seen in H/ACA ribonucleoprotein complexes. Additionally, the availability of substrate tRNAs and the cellular demand for translation can influence the overall level of pseudouridylation. Further research is needed to elucidate specific regulatory pathways.

tRNA pseudouridine(32) synthase activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
PUS1Mitochondrial myopathy and sideroblastic anemiaKnockout or point-mutation in human cell lines; mitochondrial function assays
PUS3Intellectual disabilityKnockout mice or patient-derived iPSCs; neuronal differentiation studies
PUS7Cancer, intellectual disabilityKnockout cancer cell lines; xenograft models; RNA-seq to assess translation
DKC1Dyskeratosis congenitaKnock-in of patient mutations in cell lines; telomere length assays
RluA (E. coli)Bacterial growth and translationDeletion mutants; growth assays; ribosome profiling
tRNA Pseudouridylation and Cancer
Alterations in tRNA modifications, including pseudouridylation, have been observed in various cancers. Dysregulated expression of pseudouridine synthases can affect translation of oncogenes and tumor suppressors, contributing to cancer progression. For example, PUS7 has been implicated in glioblastoma and other malignancies, though direct evidence for GO:0160151 in cancer is still emerging.
Neurological Disorders Linked to tRNA Modification Defects
Mutations in genes encoding tRNA pseudouridine synthases, such as PUS3 and PUS7, are associated with intellectual disability and neurodevelopmental disorders. These defects highlight the critical role of tRNA modifications in neuronal function and development. While GO:0160151 specifically refers to position 32, similar principles apply to other tRNA pseudouridylation events.
Mitochondrial Diseases and Pseudouridylation
PUS1 mutations cause mitochondrial myopathy and sideroblastic anemia, underscoring the importance of tRNA pseudouridylation in mitochondrial function. Although PUS1 primarily modifies other positions, the broader pathway of tRNA modification is essential for mitochondrial translation.

From tRNA pseudouridine(32) synthase activity-Related Genes to Experimental Models

Research QuestionSuitable Model
What is the effect of loss of tRNA pseudouridine(32) synthase on translation?Knockout cell lines (e.g., RluA deletion in E. coli or PUS knockout in human cells)
How does a specific point mutation in the enzyme affect its activity?Point-mutation knock-in cell lines expressing mutant enzyme
Can we tag the enzyme to study its localization and interactions?Knock-in of epitope-tagged enzyme (e.g., FLAG, GFP)
What happens when the enzyme is overexpressed?Overexpression cell lines with inducible promoters
Which genes are synthetic lethal with tRNA pseudouridine(32) synthase loss?CRISPR library screening in knockout background
How does the modification affect codon-specific translation?Ribo-seq and tRNA sequencing in knockout/overexpression models

How to Study the tRNA pseudouridine(32) synthase activity Process

MethodWhat It MeasuresTypical Application
RNA-seqGlobal tRNA expression and modification levelsComparing wild-type and mutant cells
Pseudo-seqPseudouridine sites at single-nucleotide resolutionMapping modification sites in tRNA
Ribo-seqTranslation efficiency and ribosome occupancyAssessing impact on protein synthesis
LC-MS/MSQuantification of pseudouridine in tRNAValidating modification changes
CRISPR screenGenetic interactions and fitness genesIdentifying synthetic lethal partners
Western blotProtein expression levelsValidating knockout or overexpression
ImmunofluorescenceSubcellular localization of tagged enzymeStudying enzyme trafficking
qRT-PCRmRNA expression of target genesConfirming gene editing outcomes
RNA Sequencing and Modification Mapping
RNA sequencing (RNA-seq) can be used to assess global changes in tRNA expression and modifications. Specialized techniques like pseudouridine sequencing (Pseudo-seq) or mass spectrometry can map pseudouridine sites, including position 32, in tRNA. These methods allow researchers to quantify the impact of genetic perturbations on tRNA modification levels.
Ribosome Profiling (Ribo-seq)
Ribo-seq provides a snapshot of translation by sequencing ribosome-protected mRNA fragments. By comparing ribosome occupancy in wild-type and mutant cells, researchers can determine how loss of tRNA pseudouridine(32) synthase affects translation efficiency and fidelity. This method is particularly useful for identifying codon-specific effects.
Mass Spectrometry for Nucleoside Analysis
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) can directly quantify pseudouridine levels in purified tRNA. This approach offers high sensitivity and specificity for detecting changes in modification status upon enzyme manipulation.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify genes that modulate the fitness of cells lacking tRNA pseudouridine(32) synthase activity. Such screens can reveal synthetic lethal interactions and pathways that compensate for the loss of this modification.

How CRISPR Can Be Used to Study GO:0160151 tRNA pseudouridine(32) synthase activity

Knockout

CRISPR knockout (KO) of the gene encoding tRNA pseudouridine(32) synthase (e.g., RluA in E. coli or PUS genes in human cells) can completely abolish the modification. This allows researchers to study the consequences of losing pseudouridine(32) on tRNA stability, translation, and cellular phenotypes. KO models are essential for determining the essentiality of the enzyme and identifying compensatory pathways.

Point Mutation

Introducing specific point mutations into the catalytic residues of the enzyme via CRISPR knock-in can dissect the mechanism of catalysis and separate enzymatic activity from other functions. For example, mutating the aspartate involved in catalysis can render the enzyme inactive, mimicking a KO but with a stable protein. This approach is valuable for studying structure-function relationships.

Knock-in

CRISPR knock-in can be used to add tags (e.g., FLAG, GFP) to the endogenous enzyme, enabling studies of its localization, interactions, and dynamics in live cells. Additionally, knock-in of disease-associated mutations can create isogenic models to study their impact on enzyme activity and tRNA modification.

Overexpression

CRISPR activation (CRISPRa) or traditional overexpression constructs can drive high-level expression of the enzyme. Overexpression models help determine if increased pseudouridylation affects translation or cellular fitness, and can be used to identify dose-dependent effects. They are also useful for producing large amounts of enzyme for biochemical studies.

How EDITGENE Supports tRNA pseudouridine(32) synthase activity Research

Researchers studying tRNA pseudouridine(32) synthase activity-related genes often need to determine whether a candidate gene is causally involved in tRNA modification and translation. EDITGENE provides comprehensive CRISPR gene editing services to create precisely tailored cell models, enabling rigorous investigation of gene function and disease mechanisms.
Contact EDITGENE today to design your custom CRISPR model for tRNA pseudouridine(32) synthase activity research.

Frequently Asked Questions About tRNA pseudouridine(32) synthase activity

It is the enzymatic activity that converts uridine at position 32 of tRNA into pseudouridine, as defined by GO:0160151.
The Escherichia coli RluA gene is a well-known example, and in humans, several PUS genes encode pseudouridine synthases, though their specificity for position 32 may vary.
Pseudouridine at position 32 stabilizes the tRNA anticodon loop, which is critical for accurate and efficient translation.
Mutations in pseudouridine synthases like PUS1, PUS3, and DKC1 are linked to mitochondrial myopathy, intellectual disability, and dyskeratosis congenita, respectively.
Methods include RNA sequencing, mass spectrometry, Ribo-seq, and CRISPR-based gene editing to create knockout or mutant cell models.
RluA catalyzes pseudouridylation of tRNA at position 32 and 23S rRNA at position 746, affecting translation and ribosome function.
Yes, CRISPR knockout, knock-in, and overexpression models allow precise manipulation of genes encoding tRNA pseudouridine(32) synthases.
Modulating tRNA pseudouridylation could be a strategy for treating diseases characterized by translation dysregulation, such as cancer and neurological disorders.
Pseudouridine at position 32 enhances tRNA structural stability and codon-anticodon interactions, thereby promoting translation fidelity.
EDITGENE provides custom CRISPR knockout, point mutation, knock-in, overexpression cell models, and CRISPR library screening with bioinformatics support.

Conclusion

tRNA pseudouridine(32) synthase activity (GO:0160151) is a fundamental molecular function that ensures proper tRNA modification and translation. Its study is essential for understanding RNA biology and disease mechanisms. With advanced CRISPR tools and services from EDITGENE, researchers can create precise models to investigate this activity and its therapeutic potential.

References

  1. 1. Raychaudhuri S et al.. 1999. Functional effect of deletion and mutation of the Escherichia coli ribosomal RNA and tRNA pseudouridine synthase RluA.. J Biol Chem 274(27):18880-6 PMID: 10383384
Contact Us
*
*
*
*
How did you hear about us: